Platelet reactivity in patients with stroke and hyperlipidemia, GPIbα assessment

Clinical and Applied Thrombosis/Hemostasis

Volumn 22, Issue 2, 2016, Pages 166-170

  Pawelczyk, Malgorzata ^a   Chmielewski, Henryk ^a   Kaczorowska, Beata ^a   Przybyła, Monika ^a   Baj, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

GPIb ; hyperlipidemia; ischemic stroke; platelet reactivity

Indexed keywords

BETA3 INTEGRIN; FIBRINOGEN; GLYCOPROTEIN IB ALPHA; MONOCLONAL ANTIBODY; THROMBIN; ADHESION RECEPTOR; ITGB3 PROTEIN, HUMAN; THROMBIN RECEPTOR;

AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; MALE; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE COUNT; BIOSYNTHESIS; BLOOD; CEREBROVASCULAR ACCIDENT; DRUG EFFECTS; FOLLOW UP; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; BRAIN ISCHEMIA; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; HYPERLIPIDEMIAS; INTEGRIN BETA3; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; STROKE; THROMBIN;

EID: 84957663054     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029614543823     Document Type: Article

References (29)

1. Marquardt L, Ruf A, Mansmann U, et al. Course of platelet activation markers after ischemic stroke. Stroke. 2002; 33 (11): 2570-2574.
2. Cha JK, Jeong MH, Jang JY, et al. Serial measurements of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis. 2003; 16 (4): 376-382.
3. Lukasik M, Rozalski M, Luzak B, Michalak S, Kozubski W, Watala C,. Platelet activation and reactivity in the convalescent phase of ischaemic stroke. Thromb Haemost. 2010; 103 (3): 644-650.
4. Ruggeri Z M,. Structure and function of von Willebrand factor. Thromb Haemost. 1999; 82 (2): 576-584.
5. Andrews RK, Lopez JA, Berndt MC,. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol. 1997; 29 (1): 91-105.
6. Lominadze D, Dean WL, Tyagi SC, Roberts AM,. Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol. 2010; 198 (1): 1-13.
7. Undas A, Ariëns RA,. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011; 31 (12): 88-99.
8. Tuttolomondo A, Pinto A, Corrao S, et al. Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. Atherosclerosis. 2009; 203 (2): 503-508.
9. Pinto A, Tuttolomondo A, Casuccio A, et al. Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). Clin Sci (Lond). 2009; 116 (10): 781-789.
10. Makihara N, Okada Y, Koga M, et al. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry. Cerebrovasc Dis. 2012; 33 (3): 240-247.
11. Canouï-Poitrine F, Luc G, Bard JM, et al. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study. Cerebrovasc Dis. 2010; 30 (3): 252-259.
12. Milionis J, Elisaf MS, Mikhailidis DP,. Platelet function and lipid-lowering interventions. Platelets. 1999; 10 (6): 357-367.
13. Nofer JR, Tepel M, Kehrel B, et al. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets: a novel mechanism enhancing platelet activity in hypercholesterolaemia. Circulation. 1997; 95 (6): 1370-1375.
14. Baker RI, Eikelboom J, Lofthouse E, et al. Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood. 2001; 98 (1): 36-40.
15. Du X,. Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr Opin Hematol. 2007; 14 (3): 262-269.
16. Esen FI, Hancer VS, Küçükkaya RD, et al. Glycoprotein Ib-alpha Kozak polymorphism in ischemic stroke. Neurol Res. 2012; 34 (1): 68-71.
17. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C,. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke. 1997; 28 (7): 1392-1395.
18. De Meyer SF, Schwarz T, Deckmyn H, et al. Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice-brief report. Arterioscler Thromb Vasc Biol. 2010; 30 (10): 1949-1951.
19. Stoll G, Kleinschnitz C, Nieswandt B,. The role of glycoprotein Ibalpha and von Willebrand factor interaction in stroke development. Hamostaseologie. 2010; 30 (3): 136-138.
20. Stokes KY, Clanton EC, Bowles KS, et al. The role of T-lymphocytes in hypercholesterolemia-induced leukocyte-endothelial interactions. Microcirculation. 2002; 9 (5): 407-417.
21. Stokes KY, Cooper D, Tailor A, Granger DN,. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med. 2002; 33 (8): 1026-1036.
22. Sener A, Ozsavci D, Oba R, Demirel GY, Uras F, Yardimci KT,. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia? Clin Biochem. 2005; 38 (12): 1081-1087.
23. Ferroni P, Basili S, Vieri M, et al. Soluble P-selectin and proinflammatory cytokines in patients with polygenic type IIa hypercholesterolemia. Haemostasis. 1999; 29 (5): 277-285.
24. Kannel WB,. Influence of fibrinogen on cardiovascular disease. Drugs. 1997; 54 (suppl 3): 32-40.
25. Maresca G, Di Blasio A, Marchioli R, Di Minno G,. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arterioscler Thromb Vasc Biol. 1999; 19 (6): 1368-1377.
26. Ernst E, Resch KL,. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993; 118 (12): 956-963.
27. Smith FB, Lee AJ, Fowkes FGR, Price JF, Rumley A, Lowe GDO,. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study. Arterioscler Thromb Vasc Biol. 1997; 17 (11): 3321-3325.
28. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1999; 100 (7): 736-742.
29. Rothwell PM, Howard SC, Power DA, et al. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke. 2004; 35 (10): 2300-2305.